IRCT20200317046797N6已完成3 期
Effect of edaravone on clinical improvement and outcome of patients with respiratory distress syndrome caused by COVID-19
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Patients with COVID-19-induced pneumonia confirmed with Polymerase chain reaction (PCR)
- •Patients with COVID-19-induced pneumonia confirmed with chest CT scan results
- •18 to 80 years old
- •Patients with acute respiratory distress syndrome (ARDS) according to Berlin ARDS criteria
排除标准
- •Patients who are participating in other drug clinical trials
- •Pregnant or lactating women
- •Patient with drug allergy
- •Patients on mechanical ventilation
- •Patients with expected survival duration< 24 h
研究者
相似试验
尚未招募
3 期
Effectivnes of edaravone on ischemic strokeIschemic stroke.Cerebral infarctionIRCT20240224061102N1Yasouj University of Medical Sciences60
已完成
不适用
Clinical study of the effectiveness of edaravone for the oxidative stress in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis (ALS)JPRN-UMIN000024854Okayama university20
招募中
3 期
Efficacy of Edaravone with Thrombolysis in Acute Ischemic StrokeIRCT20210530051440N1Zanjan University of Medical Sciences244
招募中
2 期
Effect of Edaravone in treatment of ALSAmyotrophic Lateral Sclerosis.Progressive muscular atrophyRestrictive lung disease due to amyotrophic lateral sclerosisRestrictive lung mechanics due to alsG12.21IRCT20190324043105N1Esfahan University of Medical Sciences20
招募中
1 期
Effects of edaravone on early postoperative cognitive function in elderly patients undergoing hip joint replacement surgeryPostoperative cognitive dysfunctionITMCTR1900002523Shanghai Pudong Hospital